Check Before You Invest : Everest Organics Ltd

Snapshot

Q.1 Which industry/sub-sector does Everest Organics Ltd belong to?

Everest Organics Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Everest Organics Ltd a good quality company?

Everest Organics Ltd is a average quality company, based on a somewhat consistent 10-year financial track record.

Q.3 Is Everest Organics Ltd undervalued or overvalued?

Everest Organics Ltd appears Fair, as its key valuation ratios are in line with their past averages.

Q.4 Is Everest Organics Ltd a good buy now?

Everest Organics Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Everest Organics Ltd?

Everest Organics Ltd revenue growth is -19.1% for FY-2025, which is below its 5-year CAGR of -0.94%, indicating slower growth.

Q.2 Return on capital employed (ROCE) of Everest Organics Ltd?

Everest Organics Ltd Return on capital employed is 1.76% for FY-2025, which is below its 5-year historical median of 6.03%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Everest Organics Ltd?

Everest Organics Ltd Return on Asset is -0.57%, which is below its 5-year historical median of 0.06%, indicating deteriorated asset utilization efficiency.

Q.4 Return on Equity (ROE) of Everest Organics Ltd?

Everest Organics Ltd Return on equity is -2.25% for FY-2025, which is below its 5-year historical median of 0.3%, indicating the business is making worse use of its shareholders capital.

Q.5 Cash conversion cycle of Everest Organics Ltd?

Everest Organics Ltd Cash conversion cycle is 49 days, above its 5-year historical median of 29 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.81	1.1
ROE	-2.25	0.3
ROCE	1.76	6.03
Cash Conversion Cycle	49 days	29 days

Q.6 Gross Profit margin of Everest Organics Ltd?

Everest Organics Ltd Gross profit margin which is the profit after deduction of direct costs, is 1.5% for FY-2025, which is below its 5-year median of 2.4%, indicating decreasing margins.

Q.7 Operating Profit Margin of Everest Organics Ltd?

Everest Organics Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 4.53% for FY-2025, which is in line with its 5-year median of 4.53% indicating stable margins.

Q.8 Net Profit Margin of Everest Organics Ltd?

Everest Organics Ltd Net Profit Margin is -0.81% for FY-2025, is below with its 5-year median of 0.07%, indicating decreasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	1.5	2.4
Operating Profit Margin	4.53	4.53
Net Profit Margin	-0.81	0.07

Q.9 Debt to Equity ratio of Everest Organics Ltd?

Everest Organics Ltd Debt-to-Equity ratio is 0.69, which is above with the industry average of 0.27, indicating higher debt levels in the industry.

Q.10 Debt to cash flow from operations of Everest Organics Ltd?

Everest Organics Ltd Debt to cash flow from operations is -8.9, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Everest Organics Ltd?

Promoters hold 59.58% of the Everest Organics Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Everest Organics Ltd vs industry peers?

Everest Organics Ltd revenue CAGR is -0.94%, compared to the industry median CAGR of 8.30%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	-19.1	8.3
Gross Profit Growth	-50	14.7
Operating Profit Growth	-36.4	11.4
Net Profit Growth	0	NAN

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.81	0.81
ROE	-2.25	9.49
ROCE	1.76	11.91
Cash Conversion Cycle (days)	49.09	85

Valuation & price assessment

Q.1 Stock return of Everest Organics Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 27.1% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	27.1%	-4.7%	36.6%	-32.4%

Q.3 Valuation ratios of Everest Organics Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	45.35	54.75	31.09
Price to Book	3.63	2.77	2.85
Price to Sales	1.4	0.64	2.79
EV to EBITDA	17.51	16.77	15.87

Check more companies

6. Wockhardt

7. Pfizer

8. Piramal Pharma

9. Acutaas Chemicals

10. Astrazeneca Pharma I

Check trending companies

1. Can Fin Homes Ltd.

2. Home First Finance Company India Ltd.

3. Sammaan Capital Ltd.

4. Force Motors Ltd.

5. KEI Industries Ltd.